Skip to main content
logo
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.9900
-0.0084 (-0.84%)
Apr 13, 2026, 2:19 PM EDT - Market open

Sunshine Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-5.98-5.13-4.51-26.74-12.44
Depreciation & Amortization
0.330.220.150.030.01
Asset Writedown & Restructuring Costs
1.75--18.33-
Stock-Based Compensation
-0.01--0.92
Other Operating Activities
0.01---0.019.79
Change in Accounts Receivable
-0.12-2.34-0.59-0.52-0.01
Change in Inventory
-1.64-6.01-2.370.04-0.08
Change in Accounts Payable
-0.193.98-1.363.36-0.02
Change in Income Taxes
--0.81-0.070.24-
Change in Other Net Operating Assets
0.5-2.45-0.020.03-0
Operating Cash Flow
-5.33-12.52-8.78-5.25-1.83
Capital Expenditures
-0.17-1.66-0.08-0.19-
Cash Acquisitions
----14.35-
Sale (Purchase) of Intangibles
-0.66-0.32-0.71-0.11-
Other Investing Activities
--0.130.03-
Investing Cash Flow
-0.84-1.98-0.66-14.62-
Long-Term Debt Issued
----3.32
Total Debt Issued
----3.32
Long-Term Debt Repaid
---0.13-1.93-0.48
Total Debt Repaid
---0.13-1.93-0.48
Net Debt Issued (Repaid)
---0.13-1.932.84
Issuance of Common Stock
4.7512.084.0943.56-
Repurchase of Common Stock
--3.14-0.54-0.1-
Other Financing Activities
----2.060.06
Financing Cash Flow
4.758.943.4339.472.9
Foreign Exchange Rate Adjustments
0.86-1.040.470.18-0.02
Net Cash Flow
-0.56-6.61-5.5319.781.06
Free Cash Flow
-5.51-14.18-8.86-5.44-1.83
Free Cash Flow Margin
-15.16%-40.67%-36.76%-125.24%-800.75%
Free Cash Flow Per Share
-1.32-20.21-690.63--
Cash Interest Paid
-0.01-0.050.04
Cash Income Tax Paid
-0.58---
Levered Free Cash Flow
-4.63-12.39-8.2-4.35-0.91
Unlevered Free Cash Flow
-4.63-12.38-8.12-4.33-0.7
Change in Working Capital
-1.45-7.63-4.423.15-0.11
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q